Juliette T. Liesinger, BA

Increased expenditures in US asthma are driven by increased medication spending that are not offset by decreases in emergency department and hospital spending.

Introduction of drug-eluting stents resulted in improved clinical outcomes for patients and reduced overall procedural costs.